+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ondansetron"

Diabetic Gastroparesis Treatment Global Market Report 2024 - Product Thumbnail Image

Diabetic Gastroparesis Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
Gastritis - Pipeline Insight, 2024 - Product Thumbnail Image

Gastritis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Serotonin 3 receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Serotonin 3 receptor antagonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Antiemetics: Technologies and Global Markets - Product Thumbnail Image

Antiemetics: Technologies and Global Markets

  • Report
  • July 2018
  • 115 Pages
  • Global
From
Gastritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Gastritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 93 Pages
  • Global
From
From
From
  • 12 Results (Page 1 of 1)
Loading Indicator

Ondansetron is a medication used to treat nausea and vomiting caused by cancer treatments, such as chemotherapy and radiation therapy. It is also used to prevent nausea and vomiting after surgery. Ondansetron is a serotonin 5-HT3 receptor antagonist, which works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting. It is available in both oral and intravenous forms. Ondansetron is a widely used medication in the gastrointestinal drugs market. It is used to treat nausea and vomiting caused by a variety of conditions, including chemotherapy, radiation therapy, and post-operative nausea and vomiting. It is also used to prevent nausea and vomiting in patients undergoing chemotherapy or radiation therapy. The market for gastrointestinal drugs is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Other companies in the market include AstraZeneca, Takeda Pharmaceuticals, and Daiichi Sankyo. Show Less Read more